FELICIA MILES: Open Payments
NPI 1265287015 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 24 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $100 |
| PFIZER INC. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Janssen Biotech, Inc. | 2 | $45 |
| MERZ NORTH AMERICA, INC. | 2 | $45 |
| Celgene Corporation | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Eisai Inc. | 1 | $29 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $28 |
Products named: KEYTRUDA, IBRANCE, Xeomin, LIBTAYO, JEMPERLI, Fabhalta, LUTATHERA, Lenvima.
Industry payments across AZ — which companies pay providers there.
